Literature DB >> 16763473

Determination of pharmacokinetic parameters in DCE MRI: Consequence of nonlinearity between contrast agent concentration and signal intensity.

Melanie Heilmann1, Fabian Kiessling, Marta Enderlin, Lothar R Schad.   

Abstract

OBJECTIVES: We sought to compare pharmacokinetic modeling of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) data by assuming a linear and nonlinear relationship between signal intensity (SI) and contrast agent (CA) concentration.
MATERIALS AND METHODS: Data sets were generated by computer-based simulation studies and DCE-MRI examination of 5 tumor-bearing mice using a 1.5 T MR-scanner. Two approaches were investigated: a linear and nonlinear relationship between SI and CA concentration before pharmacokinetic analysis. In a pharmacokinetic 2-compartment model, values of exchange rate constant kep and amplitude A were compared for both assumptions.
RESULTS: In the linear approach, A was as much as 30% less for kep values between 1.0 and 5.0 min, whereas kep was as much as 60% greater, for kep between 0.2 and 5.0 min compared with the nonlinear one, as demonstrated in simulations and animal studies.
CONCLUSIONS: Nonlinearity between SI and CA concentration has to be considered for accurate parameter calculation in DCE-MRI studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763473     DOI: 10.1097/01.rli.0000209607.99200.53

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  18 in total

1.  Response of HT29 colorectal xenograft model to cediranib assessed with 18 F-fluoromisonidazole positron emission tomography, dynamic contrast-enhanced and diffusion-weighted MRI.

Authors:  Louisa Bokacheva; Khushali Kotedia; Megan Reese; Sally-Ann Ricketts; Jane Halliday; Carl H Le; Jason A Koutcher; Sean Carlin
Journal:  NMR Biomed       Date:  2012-07-08       Impact factor: 4.044

2.  Water exchange-minimizing DCE-MRI protocol to detect changes in tumor vascular parameters: effect of bevacizumab/paclitaxel combination therapy.

Authors:  Wenlian Zhu; Yoshinori Kato; Dmitri Artemov
Journal:  MAGMA       Date:  2013-06-27       Impact factor: 2.310

3.  Uncertainty and bias in contrast concentration measurements using spoiled gradient echo pulse sequences.

Authors:  Matthias C Schabel; Dennis L Parker
Journal:  Phys Med Biol       Date:  2008-04-17       Impact factor: 3.609

4.  Precision analysis of kinetic modelling estimates in dynamic contrast enhanced MRI.

Authors:  Dieter De Naeyer; Yves De Deene; Wim P Ceelen; Patrick Segers; Pascal Verdonck
Journal:  MAGMA       Date:  2011-01-08       Impact factor: 2.310

5.  Modification of population based arterial input function to incorporate individual variation.

Authors:  Harrison Kim
Journal:  Magn Reson Imaging       Date:  2017-09-27       Impact factor: 2.546

6.  Dynamic contrast-enhanced MR microscopy identifies regions of therapeutic response in a preclinical model of colorectal adenocarcinoma.

Authors:  Ergys Subashi; Yi Qi; G Allan Johnson
Journal:  Med Phys       Date:  2015-05       Impact factor: 4.071

7.  Tumor location, but not H3.3K27M, significantly influences the blood-brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma.

Authors:  Ergys Subashi; Francisco J Cordero; Kyle G Halvorson; Yi Qi; John C Nouls; Oren J Becher; G Allan Johnson
Journal:  J Neurooncol       Date:  2015-10-28       Impact factor: 4.130

8.  Treatment response assessment of breast masses on dynamic contrast-enhanced magnetic resonance scans using fuzzy c-means clustering and level set segmentation.

Authors:  Jiazheng Shi; Berkman Sahiner; Heang-Ping Chan; Chintana Paramagul; Lubomir M Hadjiiski; Mark Helvie; Thomas Chenevert
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

9.  A comparison of radial keyhole strategies for high spatial and temporal resolution 4D contrast-enhanced MRI in small animal tumor models.

Authors:  Ergys Subashi; Everett J Moding; Gary P Cofer; James R MacFall; David G Kirsch; Yi Qi; G Allan Johnson
Journal:  Med Phys       Date:  2013-02       Impact factor: 4.071

10.  Assessment of the early effects of 5,6-dimethylxanthenone-4-acetic acid using macromolecular contrast media-enhanced magnetic resonance imaging: ectopic versus orthotopic tumors.

Authors:  Mukund Seshadri; David A Bellnier; Richard T Cheney
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-15       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.